Close

Letter to the Honorable John Carey

Letter to the Honorable John Carey, Chairman of the Senate Committee on Finance and Financial Institutions in Ohio from BIO, regarding House Bill 66.

BIO Proposal for Reform of Brazil’s Bioprospecting and Genetic Resources Regulations

BIO welcomes the opportunity to provide the views of its members on facilitating access to genetic resources and traditional knowledge and the sharing of benefits from their use...

Biotech Leader Provides Testimony on Bioethical Issues in International Clinical Trials

A timely and consistent regulatory process will ultimately result in medical treatments and cures for some of the most devastating and life-threatening diseases... 

BIO Statement to the Presidential Commission for the Study of Bioethical Issues: Principles Regarding Ethical Performance of International Clinical Trials

Recent reports have raised concerns about how clinical trials are being performed in other countries, particularly in the developing world...

BIO Welcomes Recommendations on Synthetic Biology from Presidential Commission for the Study of Bioethical Issues

Research and development in synthetic biology is an evolution of biotechnology innovation that should be supported and encouraged by federal regulatory policies... 

BIO Hails Court of Appeals Action to Lift Injunction on Embryonic Stem Cell Research

BIO President and CEO Jim Greenwood released the following statement on action by the U.S. Circuit Court of Appeals last night to stay the lower court’s injunction on federally funded embryonic stem cell research...

BIO Comments on Court Injunction Blocking Federal Funding of Embryonic Stem Cell Research

BIO President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research...

Synthetic Biology and its Practical Applications to Be Highlighted at World Congress on Industrial Biotechnology and Bioprocessing

Achievement of a milestone in creating synthetic life in the form of a self-replicating cell from synthesized DNA has focused attention on the field of synthetic biology...

Bioethics and the Biotech Industry at the 2010 BIO International Convention

Michael Werner, a partner at Holland & Knight, about the new stem cell guidelines issued by the NIH.

BIO Comments, National Institutes of Health: Promoting Objectivity in Research for Which Public Health Service Funding is Sought and Responsible Prospective Contractors

 BIO thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the advanced notice of proposed rulemaking regarding conflict of interest in federally funded medical research, published in the Federal Register on May 8, 2009...